TAIGEN BIOPHARMACEUTICALS HLDGS LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 4157 for the last quarter is 8.61 M TWD, and it's 92.91% lower compared to the previous quarter. The net income of Q3 24 is -71.97 M TWD.